News Announcement

Panacea Biotec: Reg.: I. Audited Financial Results (Standalone And Consolidated) For The
Quarter / Year Ended 31St March, 2018
Ii. Passing Over Of Dividend For The Financial Year 2017-18

We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 30.05.2018, inter-alia, considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Year ended 31.03.2018. The same were also reviewed by the Audit Committee in its meeting held on 29.05.2018.

Pursuant to Regulation 33 of SEBI Listing Regulations, 2015, a copy of the Statement of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31.03.2018 along with Auditors Report on the Audited Financial Results is enclosed for your reference and record.

Further, in view of losses, the Board of Directors has not recommended any dividend on the Preference as well as Equity Shares of the Company for the financial year ended 31.03.2018.

We request you to kindly bring the above information to the notice of your members.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds